CN111084788A - Artificial intercellular substance - Google Patents

Artificial intercellular substance Download PDF

Info

Publication number
CN111084788A
CN111084788A CN201811235590.0A CN201811235590A CN111084788A CN 111084788 A CN111084788 A CN 111084788A CN 201811235590 A CN201811235590 A CN 201811235590A CN 111084788 A CN111084788 A CN 111084788A
Authority
CN
China
Prior art keywords
intercellular substance
artificial
substance
intercellular
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811235590.0A
Other languages
Chinese (zh)
Inventor
马雪松
顾苏兰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Lan'ang Electronic Technology Development Co ltd
Original Assignee
Shanghai Lan'ang Electronic Technology Development Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Lan'ang Electronic Technology Development Co ltd filed Critical Shanghai Lan'ang Electronic Technology Development Co ltd
Priority to CN201811235590.0A priority Critical patent/CN111084788A/en
Publication of CN111084788A publication Critical patent/CN111084788A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8967Lilium, e.g. tiger lily or Easter lily
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)

Abstract

The invention relates to an artificial intercellular substance, belonging to the field of biological medicine. The invention uses artificial simulation or manufacturing 'artificial intercellular substance' with the same or similar function and physical index as the 'intercellular substance' of healthy organism, or uses technical means to collect the 'natural intercellular substance' with normal function in the fresh remains of healthy organism. So long as a living body's "intercellular substance" is not used, it is within the scope of the present invention. The invention avoids slaughtering living organisms, protects lives, and provides an environment-friendly, cheap and fully-supplied 'intercellular substance' source for modern biology.

Description

Artificial intercellular substance
Technical Field
The invention relates to an artificial intercellular substance, belonging to the field of biological medicine.
Background
The smallest constituent unit of a multicellular organism is a cell, and the cell clusters are recombined into various tissues to finally form the organism. In fact, however, there is another essential component of the organism, namely the "intercellular substance", which exists between the cell membrane and the cells and is a substance produced by the cells without cellular morphology and structure. The material and energy exchange between cells depends on the intercellular substance. The composition of the intercellular substance varies from species to species, such as the "intercellular substance" of mammals, including fibers, matrix, and fluid substances (interstitial fluid, lymph fluid, plasma, etc.).
The 'intercellular substance' has great application value in the fields of scientific research, biological medicine and the like.
Disclosure of Invention
The content of the invention is to artificially simulate or produce an artificial intercellular substance with the same or similar function and physical indexes as those of a healthy organism, or collect a natural intercellular substance with normal function in a fresh remains of the healthy organism by using a technical means.
The invention solves the traditional idea of obtaining the intercellular substance by using living organisms, avoids butchering and killing the living organisms, and provides an environment-friendly, cheap and fully-supplied intercellular substance source for modern biology.
The inventor finds that the main components of the intercellular substance are divided into fiber, matrix and fluid substances. The intercellular substance is also a solution in nature and thus can be divided into two parts, a solvent and a solute. The solvent is water, and is water treated by the cells themselves. The solute is complex in composition, but mainly comprises three types, namely salt, cellulose and protein, and also comprises components with extremely low content such as carbon dioxide and oxygen dissolved in water. The fiber components referred by the inventor comprise fibers and semi-fiber substances, and the protein comprises polypeptide, amino acid, macromolecular protein and the like.
The inventors have found that some components can be simplified, naturally produced or even omitted if the intercellular substance is artificially prepared. Such as carbon dioxide, etc. dissolved in water, if the water for preparation or the finished product is exposed to the air for a period of time, the corresponding gas component will be dissolved in the water or the finished product naturally, and no special addition is needed. Among protein components, macromolecular proteins are certainly necessary, polypeptides can be simplified into one or more common types, and fibers can be omitted. Practical application shows that the principle does not influence the application effect and the support of cell functions.
The inventor determines the kind of raw materials and the key preparation process for artificially preparing the intercellular substance through a large number of experiments.
The solvent is selected from water, but higher purity is required, distilled water can be adopted, but triple distilled water is most suitable and can be easily obtained under the existing industrial technology. The salts mainly play a role in ion balance and substance supplement, so sodium, potassium, calcium ions and salts thereof are necessary, other trace ions such as iron, magnesium, zinc, chlorine, hydroxide radical and the like can be added in a proper amount, and when the salt is used in vitro, only the main species can be added to meet the requirement. Experiments prove that the salts can adopt sodium chloride, potassium chloride, calcium chloride, zinc gluconate, ferrous lactate and the like, and no extra hydroxide is needed. The inventor also finds that if salt components are required to be enriched as much as possible, plant water extracts such as water extracts of ginkgo, arbutin, lily and the like can be selected, and the effect is better. The protein can be selected from collagen, hyaluronic acid and the like, if the plant water extract is added, the protein (the invention also comprises polypeptide, amino acid and the like) is more abundant, and the cost can be saved, the preparation process can be simplified and the use effect can be improved.
Of course, the artificial preparation method, regardless of the abundance of the components and the perfection of the functions, is inevitably inferior to the natural intercellular substance. Thus, the inventors have also identified a method for extracting the intercellular substance from a freshly dead organism.
First, the death time of the organism should be within one hour. Secondly, the invention is primarily intended for human use, and therefore the biological species is mammalian in nature, but other species of organisms may be used to extract the intercellular substance in a similar manner.
In the case of mammals, not all parts are suitable for extraction, such as bone, nervous system, digestive system, etc., which are not suitable. Suitable sites are muscle tissue and joint cavities. After the fresh muscle tissue is stripped from the body, the tissue is cut into slices of 2-10 microns by an ultrathin blade for pathological section, and the slices are optimally cut in the direction perpendicular to the muscle fibers. Then, the medium-speed filter paper is horizontally paved up and down along the section and is placed in a Buchner funnel, preferably, only one filter paper is used, and the extraction effect can be influenced by the superposition of a plurality of filter papers. The filter paper is lightly pressed with a medical grade plastic plate or a suitable instrument with a force to press the liquid without crushing the slices. Finally, the extract is extracted and stored at 4 ℃.
The artificial intercellular substance has positive social benefit and economic benefit, not only protects life, is green and environment-friendly, but also has cost far lower than that of the intercellular substance of living organisms.
It is clear that it is within the scope of the invention to use "intercellular substance" of the living body, as long as it is not used. The method for producing the "artificial intercellular substance" is many and not limited to the examples.
Detailed Description
1) The preparation process of "artificial intercellular substance" used in vitro.
The solvent is selected from triple distilled water. And (3) standing the triple distilled water in a sterile environment for 1 hour to dissolve the water-soluble gas components in the air into the triple distilled water. Then, the salts are fed first. The salts comprise sodium chloride (content: 0.85%), potassium chloride (content: 0.5%), calcium chloride (content: 0.2%), folium Ginkgo water extract (content: 0.01%), and Bulbus Lilii water extract (content: 0.005%). After stirring and dissolving, the protein component is fed. Comprises collagen (content: 0.1%), sodium hyaluronate (0.05%). And (4) stirring uniformly. Standing for 24 hr, and stirring to completely homogenize. Storing at 4 deg.C. The preservation period is 4 weeks. If the concentration of sodium chloride is increased to 1.5% or more, the finished product can be stored at normal temperature for at least 6 months.
2) A process for extracting natural intercellular substance.
A fresh remains of a healthy organism whose death has been confirmed is prepared by collecting a clean muscle tissue and cutting the muscle tissue into small pieces of about 5cm by 5 cm. And cutting into slices with a cross section of about 2 microns by using an ultrathin blade for the sterilized pathological section in a direction perpendicular to muscle fibers. And (3) clamping the slices between two pieces of filter paper by using two sterilized medium-speed filter paper slightly larger than the section to form a three-layer structure. The three-layer structure is placed in a medium Buchner funnel, and the filter paper is lightly pressed by using a sterilized dry PP plastic sheet or a sterilized glass pestle, wherein the force is not required to crush the slices, but the liquid is preferably leaked out. The fluid is the intercellular substance. After the liquid is leaked out to the maximum extent, the liquid is sucked in a closed manner from the outlet end of the Buchner funnel by a disposable syringe, and the intercellular substance is sucked and collected. Then stored at 4 ℃. The process can be repeated continuously for many times, and a large amount of natural intercellular substance can be effectively collected. The whole extraction process is preferably completed within 10-20 minutes. If low temperature operating conditions are present, the time can be extended to 1 hour.

Claims (5)

1. An artificial intercellular substance is characterized by being artificially simulated or manufactured.
2. An artificial intercellular substance characterized in that each index is the same as or similar to that of a healthy organism.
3. An artificial intercellular substance is characterized in that a functional natural intercellular substance can be collected.
4. An "artificial intercellular substance" characterized in that the collection subject is not a living body.
5. An artificial intercellular substance is characterized in that the collection object is selected from fresh remains of healthy organisms.
CN201811235590.0A 2018-10-22 2018-10-22 Artificial intercellular substance Pending CN111084788A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811235590.0A CN111084788A (en) 2018-10-22 2018-10-22 Artificial intercellular substance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811235590.0A CN111084788A (en) 2018-10-22 2018-10-22 Artificial intercellular substance

Publications (1)

Publication Number Publication Date
CN111084788A true CN111084788A (en) 2020-05-01

Family

ID=70392522

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811235590.0A Pending CN111084788A (en) 2018-10-22 2018-10-22 Artificial intercellular substance

Country Status (1)

Country Link
CN (1) CN111084788A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830708A (en) * 1995-06-06 1998-11-03 Advanced Tissue Sciences, Inc. Methods for production of a naturally secreted extracellular matrix
CN102357259A (en) * 2011-07-28 2012-02-22 王珊珊 Bioprotein sponge and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830708A (en) * 1995-06-06 1998-11-03 Advanced Tissue Sciences, Inc. Methods for production of a naturally secreted extracellular matrix
CN102357259A (en) * 2011-07-28 2012-02-22 王珊珊 Bioprotein sponge and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
陶桓乐: "《中国医学百科全书》", 31 March 1984, 上海科学技术出版社 *

Similar Documents

Publication Publication Date Title
US11884953B2 (en) Method for preparing protein peptide based on connective tissue and prepared protein peptide and use thereof
CN104195205B (en) Method and prepared high activity collagen peptide and application thereof from animal placenta preparation high activity collagen peptide
CN105018555A (en) Preparation method of giant salamander skin collagen peptide
CN101063161A (en) Coproduction technique for collagen and chondroitin sulfate
CN106031709B (en) Milt DNA-NA, nucleoprotamine extract and preparation method thereof
CN113876623B (en) Application of hyaluronic acid oligosaccharide composition in resisting skin aging and promoting collagen production
CN110760509A (en) Method for extracting milt component of globefish testis
CN103386144A (en) Preparation method of fish collagen combined chitosan biological dressing
CN103467621A (en) Preparation method of high-purity sturgeon chondroitin sulfate
CN104083299A (en) Preparation method and product of deep sea fish skin collagen polypeptide peeling mask
CN104987358B (en) A kind of preparation method of pilose antler protein extract
CN105420325A (en) Placenta polypeptide preparation method
CN102559823B (en) Frog peel extract and extracting method thereof
CN106032546A (en) Method for extracting medical material-based collagen from fish scales
CN111084788A (en) Artificial intercellular substance
CN104987359A (en) Velvet antler protein extract and application and medicinal preparation thereof
CN112156112A (en) Preparation method and application of effective part of animal bone marrow
CN107595758A (en) A kind of amnion emulsion preparation method, amnion emulsion glue connection facial mask and preparation method thereof
CN115216441A (en) Composite scaffold for three-dimensional culture of stem cells and preparation method thereof
CN113122604A (en) Sea intestine glue and preparation method and application thereof
RU2562581C1 (en) Method of producing biologically active agent from sea cucumber, having general tonic and immunomodulating properties
JPH0450293B2 (en)
CN107802527B (en) Pressed powder prepared from edible fungus source composite dressing and preparation method thereof
CN108113916B (en) Natural repair peptide mask liquid and preparation method thereof
CN104490850A (en) Collagen polypeptide skin photo-damage repairing film and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination